speb/financial-data huggingface dataset:
BYL.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2592000.00
BYL.TO income_statement (annual, 2022-12-31) — Operating Income: -9870000.00
BYL.TO income_statement (annual, 2022-12-31) — Operating Revenue: 78221000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 80304975.00
BYL.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 4604000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 11230000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Other Equity Interest: 5525000.00
BYL.TO income_statement (annual, 2022-12-31) — Other Gand A: 21236000.00
BYL.TO income_statement (annual, 2022-12-31) — Other Income Expense: 393000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4261000.00
BYL.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2829000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 300000.00
BYL.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 256000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Other Payable: 502000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Other Properties: 421000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 2552000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Payables: 19380000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 24855000.00
BYL.TO cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
BYL.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1306000.00
BYL.TO income_statement (annual, 2022-12-31) — Pretax Income: -12562000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
BYL.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
BYL.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1627000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 8944000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Receivables: 22846000.00
BYL.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 49369000.00
BYL.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 7878000.00
BYL.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -5016000.00
BYL.TO income_statement (annual, 2022-12-31) — Research And Development: 10666000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -192805000.00
BYL.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 23000.00
BYL.TO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 6820000.00
BYL.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 28056000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Share Issued: 80304975.00
BYL.TO income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
BYL.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1375000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: -3260000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -7521000.00
BYL.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 103005.30
BYL.TO income_statement (annual, 2022-12-31) — Tax Provision: 101000.00
BYL.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
BYL.TO cash_flow (annual, 2022-12-31) — Taxes Refund Paid: 0.00
BYL.TO balance_sheet (annual, 2022-12-31) — Total Assets: 74384000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 1344000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Total Debt: 44827000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -3260000.00
BYL.TO income_statement (annual, 2022-12-31) — Total Expenses: 88091000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 77644000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 23931000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 16743000.00
BYL.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -9870000.00
BYL.TO income_statement (annual, 2022-12-31) — Total Other Finance Cost: 60000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 326000.00
BYL.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 393000.00
BYL.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 393000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Work In Process: 2219000.00
BYL.TO balance_sheet (annual, 2022-12-31) — Working Capital: -10448000.00
BYL.TO income_statement (annual, 2022-12-31) — Write Off: 0.00
BYL.TO income_statement (annual, 2023-12-31) — +Operating Expense: 37196000.00
BYL.TO income_statement (annual, 2023-12-31) — +Total Revenue: 73041000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 9062000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 8861000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -19669000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
BYL.TO cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 1332000.00
BYL.TO cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 1332000.00
BYL.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: -3356000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 7885000.00
BYL.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 87303110.00
BYL.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.16
BYL.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 7379000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 11718000.00
BYL.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -312000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 7648000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 187767000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 4903000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 4903000.00
BYL.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 5109000.00
BYL.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -33000.00
BYL.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -3551000.00
BYL.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: -262000.00
BYL.TO cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: -3525000.00
BYL.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: -2119000.00
BYL.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -1873000.00
BYL.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -635000.00
BYL.TO cash_flow (annual, 2023-12-31) — Change In Payable: -2119000.00
BYL.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -2119000.00
BYL.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 7611000.00
BYL.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 2984000.00
BYL.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 7611000.00
BYL.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -2262000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Common Stock: 187767000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: -36000.00
BYL.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 14809000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Construction In Progress: 33000.00
BYL.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 44643000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 5089000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Assets: 43231000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 901000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Debt: 17690000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 18591000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 3821000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 3821000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 47809000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Current Provisions: 2019000.00
BYL.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 146000.00
BYL.TO cash_flow (annual, 2023-12-31) — Deferred Tax: 146000.00
BYL.TO cash_flow (annual, 2023-12-31) — Depreciation: 2550000.00
BYL.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 3882000.00
BYL.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 3882000.00
BYL.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 87303110.00
BYL.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.16
BYL.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -13852000.00
BYL.TO income_statement (annual, 2023-12-31) — EBIT: -3692000.00
BYL.TO income_statement (annual, 2023-12-31) — EBITDA: 190000.00
BYL.TO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -33000.00
BYL.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -214000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Employee Benefits: 0.00
BYL.TO cash_flow (annual, 2023-12-31) — End Cash Position: 4903000.00
BYL.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 4847000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Finished Goods: 4862000.00
BYL.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -7388000.00
BYL.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -10000.00
BYL.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1820000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 11126000.00
BYL.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 18637000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2930000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 8861000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 31880000.00
BYL.TO income_statement (annual, 2023-12-31) — Gross Profit: 28398000.00
BYL.TO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
BYL.TO balance_sheet (annual, 2023-12-31) — Income Tax Payable: 57000.00
BYL.TO income_statement (annual, 2023-12-31) — Interest Expense: 4379000.00
BYL.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 4379000.00
BYL.TO income_statement (annual, 2023-12-31) — Interest Income: 2000.00
BYL.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2000.00
BYL.TO cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -3946000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Inventory: 17623000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 20975000.00
BYL.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -33000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 167000.00
BYL.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 16509000.00
BYL.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 4753000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Land And Improvements: 6122000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Leases: 596000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Line Of Credit: 17690000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 6747000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 3321000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 10068000.00
BYL.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -870000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 167000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 13025000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 14809000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Net Debt: 16108000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 774000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Income: -13852000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -13852000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -8217000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -5635000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -13852000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -8217000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -8217000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -13852000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Interest Income: -4449000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -11400000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -870000.00
BYL.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -4449000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 240000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Net PPE: 12211000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -273000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 1700000.00
BYL.TO cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -10530000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -2966000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 1171000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 0.00
BYL.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 0.00
BYL.TO balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 0.00
BYL.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -4986000.00
BYL.TO income_statement (annual, 2023-12-31) — Normalized Income: -11322600.00
BYL.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -7076000.00
BYL.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 731000.00
BYL.TO income_statement (annual, 2023-12-31) — Operating Income: -8798000.00
BYL.TO income_statement (annual, 2023-12-31) — Operating Revenue: 73041000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 150823586.00
BYL.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 8868000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 11126000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Other Equity Interest: 7728000.00
BYL.TO income_statement (annual, 2023-12-31) — Other Gand A: 18637000.00
BYL.TO income_statement (annual, 2023-12-31) — Other Income Expense: 5176000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2930000.00
BYL.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2116000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 169000.00
BYL.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1163000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Other Payable: 302000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Other Properties: 386000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 2744000.00
BYL.TO income_statement (annual, 2023-12-31) — Other Special Charges: -3356000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Payables: 9421000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 14510000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 1700000.00
BYL.TO cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 1700000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1215000.00
BYL.TO income_statement (annual, 2023-12-31) — Pretax Income: -8071000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
BYL.TO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 391000.00
BYL.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -312000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 9347000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Receivables: 11605000.00
BYL.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 44643000.00
BYL.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 3882000.00
BYL.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -16153000.00
BYL.TO income_statement (annual, 2023-12-31) — Research And Development: 11455000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -206657000.00
BYL.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 39000.00
BYL.TO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 7104000.00
BYL.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 25741000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Share Issued: 150823586.00
BYL.TO cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 4753000.00
BYL.TO cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -15283000.00
BYL.TO income_statement (annual, 2023-12-31) — Special Income Charges: 3356000.00
BYL.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2265000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: -36000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -2966000.00
BYL.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 2070400.00
BYL.TO income_statement (annual, 2023-12-31) — Tax Provision: 146000.00
BYL.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.40
BYL.TO cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -547000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Total Assets: 59710000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 3285000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Total Debt: 28659000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -36000.00
BYL.TO income_statement (annual, 2023-12-31) — Total Expenses: 81839000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 59746000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 16479000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 11937000.00
BYL.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -5442000.00
BYL.TO income_statement (annual, 2023-12-31) — Total Other Finance Cost: 72000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 57000.00
BYL.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 5176000.00
BYL.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 5176000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Work In Process: 3414000.00
BYL.TO balance_sheet (annual, 2023-12-31) — Working Capital: -4578000.00
BYL.TO income_statement (annual, 2023-12-31) — Write Off: 0.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Amortization Cash Flow: 80000.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Amortization Of Intangibles: 80000.00
BYL.TO balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 7069000.00
BYL.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 151118446.00
BYL.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.02
BYL.TO cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 513000.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Change In Payable: 513000.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
BYL.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 151118446.00
BYL.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.02
BYL.TO balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 2689000.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
BYL.TO balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 3078000.00
BYL.TO balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1195000.00
BYL.TO income_statement (quarterly, 2024-09-30) — Other Special Charges: -881000.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 0.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Provisionand Write Offof Assets: 0.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
BYL.TO cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: -364000.00
BYL.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: 881000.00
BYL.TO income_statement (annual, 2024-12-31) — +Operating Expense: 36311000.00
BYL.TO income_statement (annual, 2024-12-31) — +Total Revenue: 83589000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 12847000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 15047000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -22719000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -22719000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -58000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -58000.00
BYL.TO cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 320000.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 80000.00
BYL.TO cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 320000.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 80000.00
BYL.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 2609000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
BYL.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 151055728.00
BYL.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.05
BYL.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4903000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 11909000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 11909000.00
BYL.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -137000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 6927000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 187871000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 5006000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5006000.00
BYL.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -566000.00
BYL.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -137000.00
BYL.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 827000.00
BYL.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: 0.00
BYL.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -363000.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: 690000.00
BYL.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: 1741000.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -121000.00
BYL.TO cash_flow (annual, 2024-12-31) — Change In Inventory: 2262000.00
BYL.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1566000.00
BYL.TO cash_flow (annual, 2024-12-31) — Change In Payable: 1741000.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Change In Payable: -121000.00
BYL.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1741000.00
BYL.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -5408000.00
BYL.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 161000.00
BYL.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -5408000.00
BYL.TO cash_flow (annual, 2024-12-31) — Changes In Cash: -239000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Common Stock: 187871000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: -8523000.00
BYL.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
BYL.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 39000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 39000.00
BYL.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 49199000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 3735000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 3735000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Assets: 37292000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 590000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Debt: 18695000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 19285000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 3255000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 3255000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 3255000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 3255000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 44375000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Current Provisions: 4062000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Current Provisions: 4062000.00
BYL.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 907000.00
BYL.TO cash_flow (annual, 2024-12-31) — Deferred Tax: 907000.00
BYL.TO cash_flow (annual, 2024-12-31) — Depreciation: 2394000.00
BYL.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2714000.00
BYL.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2714000.00
BYL.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 151055728.00
BYL.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.05
BYL.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -7854000.00
BYL.TO income_statement (annual, 2024-12-31) — EBIT: -4504000.00
BYL.TO income_statement (annual, 2024-12-31) — EBITDA: -1790000.00
BYL.TO cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -56000.00
BYL.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 342000.00
BYL.TO cash_flow (annual, 2024-12-31) — End Cash Position: 5006000.00
BYL.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -566000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 4432000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Finished Goods: 4432000.00
BYL.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 327000.00
BYL.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
BYL.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 46000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 8375000.00
BYL.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 16153000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
BYL.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 15105000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 15105000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 33098000.00
BYL.TO income_statement (annual, 2024-12-31) — Gross Profit: 34390000.00
BYL.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 2609000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 325000.00
BYL.TO income_statement (annual, 2024-12-31) — Interest Expense: 3049000.00
BYL.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3049000.00
BYL.TO income_statement (annual, 2024-12-31) — Interest Income: 46000.00
BYL.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 46000.00
BYL.TO cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -2476000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Inventory: 14739000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 15226000.00
BYL.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -137000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 222000.00
BYL.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
BYL.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 424000.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: -252000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 6502000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 6502000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Leases: 645000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Leases: 645000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Line Of Credit: 18695000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 6337000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 5054000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 11391000.00
BYL.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -990000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 222000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 13616000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 13616000.00
BYL.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
BYL.TO balance_sheet (annual, 2024-12-31) — Net Debt: 18743000.00
BYL.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -2306000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Income: -7854000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -7854000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -8460000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 606000.00
BYL.TO income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 3706000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -7854000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -8460000.00
BYL.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -8460000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -7854000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Interest Income: -3069000.00
BYL.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -566000.00
BYL.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -990000.00
BYL.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -3069000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Net PPE: 10379000.00
BYL.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -137000.00
BYL.TO cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
BYL.TO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 424000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -8523000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 1273000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 1273000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 66000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 66000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 66000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 66000.00
BYL.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 773000.00
BYL.TO income_statement (annual, 2024-12-31) — Normalized Income: -6281450.00
BYL.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 464000.00
BYL.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -2362000.00
BYL.TO income_statement (annual, 2024-12-31) — Operating Income: -1921000.00
BYL.TO income_statement (annual, 2024-12-31) — Operating Revenue: 83589000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 151421995.00
BYL.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 392000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 392000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 8375000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Other Equity Interest: 9313000.00
BYL.TO income_statement (annual, 2024-12-31) — Other Gand A: 16153000.00
BYL.TO income_statement (annual, 2024-12-31) — Other Income Expense: -2563000.00
BYL.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 4555000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 157000.00
BYL.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -1486000.00
BYL.TO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -734000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Other Payable: 474000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Other Payable: 474000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Other Properties: 387000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 1483000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 1483000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Payables: 13646000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 17381000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 1700000.00
BYL.TO cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
BYL.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1017000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1017000.00
BYL.TO income_statement (annual, 2024-12-31) — Pretax Income: -7553000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
BYL.TO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 2004000.00
BYL.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -137000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 7758000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Raw Materials: 7758000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Receivables: 16530000.00
BYL.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 49199000.00
BYL.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2714000.00
BYL.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -990000.00
BYL.TO income_statement (annual, 2024-12-31) — Research And Development: 12235000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
BYL.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -214082000.00
BYL.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
BYL.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 7923000.00
BYL.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 24076000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Share Issued: 151421995.00
BYL.TO cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 424000.00
BYL.TO cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: -252000.00
BYL.TO cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
BYL.TO income_statement (annual, 2024-12-31) — Special Income Charges: -2609000.00
BYL.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: -3490000.00
BYL.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1689000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: -8523000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -8523000.00
BYL.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -384450.00
BYL.TO income_statement (annual, 2024-12-31) — Tax Provision: 907000.00
BYL.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
BYL.TO cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -514000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Total Assets: 49166000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: -3469000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Total Debt: 30676000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -8523000.00
BYL.TO income_statement (annual, 2024-12-31) — Total Expenses: 85510000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 57689000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 11874000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 13314000.00
BYL.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -4530000.00
BYL.TO income_statement (annual, 2024-12-31) — Total Other Finance Cost: 66000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 325000.00
BYL.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -2563000.00
BYL.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -2563000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Work In Process: 2549000.00
BYL.TO balance_sheet (quarterly, 2024-12-31) — Work In Process: 2549000.00
BYL.TO balance_sheet (annual, 2024-12-31) — Working Capital: -7083000.00
BYL.TO income_statement (annual, 2024-12-31) — Write Off: 2609000.00
BYL.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 9136000.00
BYL.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 18866000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 22982000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 11496000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 0.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 0.00
BYL.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 151423531.00
BYL.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.01
BYL.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 5006000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 7801000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 187961000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5964000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5964000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1737000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 2679000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 0.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -150000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 117000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -373000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: -150000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -150000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3554000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 3148000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 3554000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 941000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 187961000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -10453000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 10863000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 35072000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 887000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 17594000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 18481000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 44068000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Current Provisions: 2187000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -42000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -42000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 608000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 608000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 608000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 151423531.00
BYL.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.01
BYL.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2042000.00
BYL.TO income_statement (quarterly, 2025-03-31) — EBIT: -1298000.00
BYL.TO income_statement (quarterly, 2025-03-31) — EBITDA: -690000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 53000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 17000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 5964000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1737000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 2678000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -159000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 8084000.00
BYL.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4190000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 10858000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 8003000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 236000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 786000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 786000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Interest Income: 11000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 11000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -481000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 14629000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 12004000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 169000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 17594000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 6914000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4863000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 11777000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -199000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 169000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 16493000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -11000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Income: -2042000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2042000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -2042000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2042000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2042000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2042000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2042000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -792000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -1737000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -199000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -792000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 10858000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -1538000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -10453000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 103000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 103000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -531000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -1886204.41
BYL.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 2679000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 619000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Operating Income: -1133000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 18866000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 151560218.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2983000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 182000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 8084000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 9626000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 4190000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -159000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 497000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1273000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 177000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 296000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 10858000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Payables: 23218000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 23218000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: 577000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 1700000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -2084000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 11496000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 10863000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 608000.00
BYL.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -199000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Research And Development: 3131000.00
BYL.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -216124000.00
BYL.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1815000.00